| 产品详情 |
| Edit |   |
|---|
| Product Name | Varenicline tartrate |
|---|
| Description | Orally active, subtype-selective partial agonist at α4β2 nicotinic receptors (Ki values are 0.06, 240, 322 and 3540 nM for α4β2, α3β4, α7, α1βγδ receptors respectively). Reduces nicotine-evoked dopamine release in vitro and decreases nicotine self-administration in vivo. Also potently activates PSAM4-5-HT3 and PSAM4-GlyR chimeric ion channels (EC50 values are 4 and 1.6 nM, respectively). Purity 99%. MW (observed): 361.37 |
|---|
| Size | 50 mg |
|---|
| Concentration | n/a |
|---|
| Applications | n/a |
|---|
| Other Names | 7,8,9,10-Tetrahydro-6,10-methano-6H-pyrazino[2,3-h][3]benzazepine tartrate |
|---|
| Gene, Accession, CAS # | CAS: 375815-87-5 |
|---|
| Catalog # | 3754/50 |
|---|
| Price | |
|---|
| Order / More Info | Varenicline tartrate from TOCRIS BIOSCIENCE
|
|---|
| Product Specific References | PubMed: 23638015, 25440006, 25648658, 30872534 |
|---|
| 产品资料 |
|
|